VCCP Health Appointed by Merck

6th August 2009

VCCP Health has been appointed by Merck Sharp and Dohme (MSD), the third largest pharmaceutical company in the world, to work on a number of projects to run across Europe.

There are several digital assignments involving some of their leading brands, Singulair (Asthma), Fosavance (Osteoporosis) and Arcoxia (Arthritis) to run in 51 countries.

The VCCP Health team are working to some very tight timelines to produce a huge range of material including four websites plus email campaigns, banners, direct mail and printed material. 

MSD has also put VCCP Health on a separate roster to develop campaigns to educate consumers on two disease areas, Migraine and Diabetes. As well as this we have also been appointed to MSD’s digital roster.